Abstract:Background
Churg-Strauss syndrome (CSS) is extremely rare in children and is associated with higher cardiopulmonary disease and mortality rates compared to adult patients (1). Treatment consists essentially of corticosteroids (CST), however patients with severe or refractory disease might benefit from combination therapy with other immunosuppressive drugs. Omalizumab, an IgE blocking mAb has been recently used to decrease asthma activity in CSS patients (2).
Objectives
We report the case of a 10-year-old girl… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.